BB Biotech AG (BB Biotech AG) Scaled Net Operating Assets : 1.08 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is BB Biotech AG Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BB Biotech AG's operating assets for the quarter that ended in Dec. 2023 was $3,048.86 Mil. BB Biotech AG's operating liabilities for the quarter that ended in Dec. 2023 was $10.45 Mil. BB Biotech AG's Total Assets for the quarter that ended in Sep. 2023 was $2,802.07 Mil. Therefore, BB Biotech AG's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 1.08.

BB Biotech AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BB Biotech AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(3048.859	-	10.45)	/	3277.575
=	0.93

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Balance Sheet Cash And Cash Equivalents
=	3049.438	-	0.579
=	3048.859

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	363.017	-	352.567	-	0
=	10.45

BB Biotech AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Sep. 2023 )
=	(3048.859	-	10.45)	/	2802.069
=	1.08

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Balance Sheet Cash And Cash Equivalents
=	3049.438	-	0.579
=	3048.859

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	363.017	-	352.567	-	0
=	10.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG (BB Biotech AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (GREY:BBAGF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

BIONz:UK BBZA:Germany BION:Switzerland

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.